Fc-erythropoietin fusion protein with improved pharmacokinetics

Details for Australian Patent Application No. 2004309063 (hide)

Owner Merck Patent GmbH

Inventors Lauder, Scott; Kress, Dorothee; Mahler, Hanns-Christian; Gillies, Stephen D.; Mueller, Robert

Agent Davies Collison Cave

Pub. Number AU-B-2004309063

PCT Pub. Number WO2005/063808

Priority 60/533,858 31.12.03 US

Filing date 22 December 2004

Wipo publication date 14 July 2005

Acceptance publication date 28 October 2010

International Classifications

C07K 14/505 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

24 August 2006 PCT application entered the National Phase

  PCT publication WO2005/063808 Priority application(s): WO2005/063808

28 October 2010 Application Accepted

  Published as AU-B-2004309063

24 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004309067-1-(azolin-2-yl) amino1,2-diphenylethane compounds for combatting insects, arachnids and nematodes

2004309056-Process for the preparation of triazolopyrimidines